Join
Live feed
·
PRReleasevia Quantisnow
Cidara Therapeutics Inc. logo

Cidara Therapeutics Announces Positive Topline Results from its Phase 2b NAVIGATE Trial Evaluating CD388, a Non-Vaccine Preventative of Seasonal Influenza

ByQuantisnow·Wall Street's wire, on your screen.
CDTX· Cidara Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CDTX (Cidara Therapeutics Inc.) and more on Quantisnow.